Nydert Per, Unbeck Maria, Pukk Härenstam Karin, Norman Mikael, Lindemalm Synnöve
Astrid Lindgren's Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Drug Healthc Patient Saf. 2020 Jan 31;12:31-40. doi: 10.2147/DHPS.S232604. eCollection 2020.
The objectives of our study were to determine drug use, type and incidence of all adverse event associated with drug or drug-related processes (Adverse Drug Events, ADE) among pediatric inpatients in relation to hospital unit and length of stay.
600 pediatric (0-18 years) admissions at a Swedish university hospital during one year were included and stratified in blocks to 150 neonatal, surgical/orthopedic, medicine and emergency-medicine unit admissions, respectively. Adverse events were identified from medical records using a pediatric trigger tool. All triggers identifying an adverse event related to drugs and drug-related devices were included. Data on drug use were extracted from the hospital drug-data warehouse.
In total, 17794 daily drug orders were administrated to 486 (81.0% exposed) admissions. Parental nutrition, potassium salts and morphine constituted half of all high-risk drugs prescribed. Two-thirds of intravenous irritating drug doses consisted of vancomycin, esomeprazole and meropenem. In 129 (21.5%) admissions, at least one ADE was identified, out of which 21 ADE were classified as more severe (National Coordinating Council Medication Error Reporting Prevention-Index, NCCMERP≥F). The ADE incidence was 47.4 (95% confidence interval: 39.4-57.3) per 1000 admission days and varied by unit category. In neonatal units, 56.9 (49.5-65.4) ADEs/1000 admission days were detected, in surgery/orthopedic 54.2 (40.3-72.8), in medicine 44.1 (33.1-58.7), and in emergency-medicine 14.3 (7.7-26.7) ADEs/1000 admission days were found. The most common types of ADEs were identified by triggers that were not directly aiming at drugs including insufficiently treated pain (incidence peaking already in the first days), skin, tissue or vascular harm (peaking at the end of the first week) and hospital-acquired infections (peaking in later admission days).
Adverse drug events are common in pediatric patients. The incidence of ADEs and type of ADE varies by hospital unit and length of hospital stay.
我们研究的目的是确定瑞典一家大学医院儿科住院患者中与药物或药物相关过程(药物不良事件,ADE)相关的药物使用情况、所有不良事件的类型和发生率,并分析其与医院科室和住院时间的关系。
纳入一年内瑞典一家大学医院600例儿科(0至18岁)住院病例,并分别按科室分为150例新生儿、外科/骨科、内科和急诊科住院病例。使用儿科触发工具从医疗记录中识别不良事件。所有识别出的与药物和药物相关设备有关的不良事件均包括在内。药物使用数据从医院药物数据仓库中提取。
总共向486例(81.0%有用药暴露)住院病例下达了17794份每日药物医嘱。肠外营养、钾盐和吗啡占所有高风险药物处方的一半。三分之二的静脉刺激性药物剂量由万古霉素、埃索美拉唑和美罗培南组成。在129例(21.5%)住院病例中,至少识别出1例ADE,其中21例ADE被归类为更严重(国家协调委员会药物错误报告预防指数,NCCMERP≥F)。ADE发生率为每1000个住院日47.4例(95%置信区间:39.4 - 57.3),且因科室类别而异。在新生儿科,每1000个住院日检测到56.9例(49.5 - 65.4)ADE,外科/骨科为54.2例(40.3 - 72.8),内科为44.1例(33.1 - 58.7),急诊科为14.3例(7.7 - 26.7)ADE/1000个住院日。最常见的ADE类型是由并非直接针对药物的触发因素识别出来的,包括疼痛治疗不充分(发生率在最初几天达到峰值)、皮肤、组织或血管损伤(在第一周结束时达到峰值)以及医院获得性感染(在住院后期达到峰值)。
药物不良事件在儿科患者中很常见。ADE的发生率和类型因医院科室和住院时间而异。